Home › Epilepsy › Pennsylvania › Pittsburgh
Epilepsy clinical trials in Pittsburgh, PA
5 studies for Epilepsy are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
RecruitingPhase 1/2
- Allegheny Health Network, Pittsburgh
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RecruitingPhase 2/3
- UPMC, Pittsburgh
Subcortical Arousal in Perceptual Awareness
Recruiting
- University of Pittsburgh Medical Center, Pittsburgh
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- UPMC Comprehensive Epilepsy Center, Pittsburgh
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RecruitingObservational study
- University of Pittsburgh, Pittsburgh
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA20 studies
- Houston, TX16 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Phoenix, AZ10 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Miami, FL8 studies
- Durham, NC8 studies
- Mountain View, CA8 studies
- Rochester, MN8 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer38 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer24 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Depression22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.